...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Design, synthesis and biological evaluation of 1-benzyl-5-oxopyrrolidine-2-carboximidamide derivatives as novel neuroprotective agents
【24h】

Design, synthesis and biological evaluation of 1-benzyl-5-oxopyrrolidine-2-carboximidamide derivatives as novel neuroprotective agents

机译:作为新型神经保护剂的1-苄基-5-氧吡咯烷-2-羧酰胺酰胺衍生物的设计,合成和生物学评价

获取原文
获取原文并翻译 | 示例
           

摘要

A series of 1-benzyl-5-oxopyrrolidine-2-carboximidamide derivatives were designed and synthesized. Their protective activities against N-methyl-D-aspartic acid (NMDA)-induced cytotoxicity were investigated in vitro. All of the compounds exhibited neuroprotective activities, especially 12k, which showed higher potency than reference compound 1 (ifenprodil). Further investigation showed that 12k could attenuate Ca2+ influx and suppress the NR2B upregulation induced by NMDA. The docking results indicated that 12k could fit well into binding site of 1 in the NR2B-NMDA receptor. Additionally, 12k exhibited excellent metabolic stability. Furthermore, the results of behavioral tests showed that compound 12k could significantly improve learning and memory in vivo. These results suggested that 12k is a promising neuroprotective drug candidate and that the NR2B-NMDA receptor is a potential target of 12k. (C) 2019 Elsevier Masson SAS. All rights reserved.
机译:设计并合成了一系列1-苄基-5-氧吡咯烷-2-羧酰胺酰胺衍生物。 研究了对N-甲基-D-天冬氨酸(NMDA)诱导的细胞毒性的保护性活性。 所有化合物都表现出神经保护活性,特别是12K,表现出比参考化合物1(IfenProdil)更高的效力。 进一步的研究表明,12K可以衰减Ca2 +流入并抑制NMDA诱导的NR2B上调。 对接结果表明12K可以很好地适合于NR2B-NMDA受体中1的结合位点。 此外,12K表现出优异的代谢稳定性。 此外,行为测试的结果表明,化合物12K可以显着改善体内的学习和记忆。 这些结果表明,12K是一个有前途的神经保护药物候选者,并且NR2B-NMDA受体是12K的潜在靶标。 (c)2019年Elsevier Masson SAS。 版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号